CN112794814A - Organic electroluminescent material and device - Google Patents

Organic electroluminescent material and device Download PDF

Info

Publication number
CN112794814A
CN112794814A CN202011271522.7A CN202011271522A CN112794814A CN 112794814 A CN112794814 A CN 112794814A CN 202011271522 A CN202011271522 A CN 202011271522A CN 112794814 A CN112794814 A CN 112794814A
Authority
CN
China
Prior art keywords
group
compound
independently
substitution
combinations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202011271522.7A
Other languages
Chinese (zh)
Inventor
T·费利塔姆
N·J·汤普森
P·沃洛汉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universal Exhibition Co
Universal Display Corp
Original Assignee
Universal Exhibition Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/683,507 external-priority patent/US11515489B2/en
Priority claimed from US17/086,989 external-priority patent/US11889708B2/en
Application filed by Universal Exhibition Co filed Critical Universal Exhibition Co
Publication of CN112794814A publication Critical patent/CN112794814A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/86Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/30Coordination compounds
    • H10K85/321Metal complexes comprising a group IIIA element, e.g. Tris (8-hydroxyquinoline) gallium [Gaq3]
    • H10K85/322Metal complexes comprising a group IIIA element, e.g. Tris (8-hydroxyquinoline) gallium [Gaq3] comprising boron
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/30Coordination compounds
    • H10K85/341Transition metal complexes, e.g. Ru(II)polypyridine complexes
    • H10K85/346Transition metal complexes, e.g. Ru(II)polypyridine complexes comprising platinum
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/40Organosilicon compounds, e.g. TIPS pentacene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/654Aromatic compounds comprising a hetero atom comprising only nitrogen as heteroatom
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6572Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6574Polycyclic condensed heteroaromatic hydrocarbons comprising only oxygen in the heteroaromatic polycondensed ring system, e.g. cumarine dyes
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1044Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1059Heterocyclic compounds characterised by ligands containing three nitrogen atoms as heteroatoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1088Heterocyclic compounds characterised by ligands containing oxygen as the only heteroatom
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K2101/00Properties of the organic materials covered by group H10K85/00
    • H10K2101/40Interrelation of parameters between multiple constituent active layers or sublayers, e.g. HOMO values in adjacent layers

Abstract

The present application relates to organic electroluminescent materials and devices. Ortho-substituted biphenyl compounds having one or more bicarbazole linkages are provided. Formulations comprising these ortho-substituted biphenyl compounds are also provided. Also provided are OLEDs and related consumer products using these ortho-substituted biphenyl compounds.

Description

Organic electroluminescent material and device
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a continuation-in-part application of U.S. patent application No. 16/683,507 filed on 11/14/2019, and is also entitled to priority from U.S. provisional application No. 63/017,220 filed on 29/4/2020 by 35u.s.c. § 119(e), the entire contents of which are incorporated herein by reference.
Technical Field
The present disclosure relates generally to organometallic compounds and formulations and various uses thereof, including use as hosts or emitters in devices such as organic light emitting diodes and related electronic devices.
Background
Photovoltaic devices utilizing organic materials are becoming increasingly popular for a variety of reasons. Many of the materials used to make such devices are relatively inexpensive, and therefore organic photovoltaic devices have the potential for cost advantages over inorganic devices. In addition, the inherent properties of organic materials (e.g., their flexibility) may make them more suitable for particular applications, such as fabrication on flexible substrates. Examples of organic optoelectronic devices include organic light emitting diodes/devices (OLEDs), organic phototransistors, organic photovoltaic cells, and organic photodetectors. For OLEDs, organic materials may have performance advantages over conventional materials.
OLEDs utilize organic thin films that emit light when a voltage is applied across the device. OLEDs are becoming an increasingly interesting technology for applications such as flat panel displays, lighting and backlighting.
One application of phosphorescent emissive molecules is in full color displays. Industry standards for such displays require pixels adapted to emit a particular color, known as a "saturated" color. In particular, these standards require saturated red, green, and blue pixels. Alternatively, OLEDs can be designed to emit white light. In conventional liquid crystal displays, an absorptive filter is used to filter the emission from a white backlight to produce red, green, and blue emissions. The same technique can also be used for OLEDs. The white OLED may be a single emission layer (EML) device or a stacked structure. Color can be measured using CIE coordinates well known in the art.
Disclosure of Invention
Ortho-substituted biphenyl compounds having one or more bicarbazole linkages are provided. Ortho-substituted biphenyls provide a twisted molecular geometry that can increase the triplet energy of the molecule, while the bicarbazole moiety provides a good charge transport moiety. These compounds can be used as hosts in phosphorescent devices to improve efficiency and extend lifetime compared to related compounds that do not have twisted geometry or bicarbazole linkages.
In one aspect, the present disclosure provides a compound comprising the structure of formula I:
Figure BDA0002777829770000021
wherein:
Yiis that
Figure BDA0002777829770000022
And Y isjIs that
Figure BDA0002777829770000023
RA、RB、RCAnd RDEach independently represents zero substitution, mono-substitution, di-substitution, or the maximum allowed number of substitutions;
each RA、RB、RCAnd RDIndependently hydrogen or a substituent selected from the group consisting of: deuterium, halo, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, oxyboronyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, and combinations thereof;
RA、RB、RCand RDComprises a carbazole moiety;
X1-X16independently is C or N; and any two substituents can be joined or fused together to form a ring.
In another aspect, the present disclosure provides formulations of the compounds of the present disclosure.
In yet another aspect, the present disclosure provides an OLED having an organic layer comprising a compound of the present disclosure.
In yet another aspect, the present disclosure provides a consumer product comprising an OLED having an organic layer comprising a compound comprising a structure of formula I as described herein.
Drawings
Fig. 1 shows an organic light emitting device.
Fig. 2 shows an inverted organic light emitting device without a separate electron transport layer.
Detailed Description
A. Term(s) for
Unless otherwise specified, the following terms as used herein are defined as follows:
as used herein, the term "organic" includes polymeric materials and small molecule organic materials that may be used to fabricate organic optoelectronic devices. "Small molecule" refers to any organic material that is not a polymer, and "small molecules" may actually be quite large. In some cases, the small molecule may include a repeat unit. For example, the use of long chain alkyl groups as substituents does not remove a molecule from the "small molecule" class. Small molecules can also be incorporated into polymers, for example as pendant groups on the polymer backbone or as part of the backbone. Small molecules can also serve as the core moiety of a dendrimer, which consists of a series of chemical shells built on the core moiety. The core moiety of the dendrimer may be a fluorescent or phosphorescent small molecule emitter. Dendrimers can be "small molecules," and all dendrimers currently used in the OLED art are considered small molecules.
As used herein, "top" means furthest from the substrate, and "bottom" means closest to the substrate. Where a first layer is described as being "disposed" over "a second layer, the first layer is disposed farther from the substrate. Other layers may be present between the first and second layers, unless it is specified that the first layer is "in contact with" the second layer. For example, a cathode may be described as "disposed over" an anode even though various organic layers are present between the cathode and the anode.
As used herein, "solution processable" means capable of being dissolved, dispersed or transported in and/or deposited from a liquid medium in the form of a solution or suspension.
A ligand may be referred to as "photoactive" when it is believed that the ligand contributes directly to the photoactive properties of the emissive material. A ligand may be referred to as "ancillary" when it is believed that the ligand does not contribute to the photoactive properties of the emissive material, but the ancillary ligand may alter the properties of the photoactive ligand.
As used herein, and as will be generally understood by those skilled in the art, if the first energy level is closer to the vacuum energy level, the first "Highest Occupied Molecular Orbital" (HOMO) or "Lowest Unoccupied Molecular Orbital" (LUMO) energy level is "greater than" or "higher than" the second HOMO or LUMO energy level. Since Ionization Potential (IP) is measured as negative energy relative to vacuum level, a higher HOMO level corresponds to an IP with a smaller absolute value (less negative IP). Similarly, a higher LUMO energy level corresponds to an Electron Affinity (EA) with a smaller absolute value (a less negative EA). On a conventional energy level diagram with vacuum levels at the top, the LUMO energy level of a material is higher than the HOMO energy level of the same material. The "higher" HOMO or LUMO energy level appears closer to the top of this figure than the "lower" HOMO or LUMO energy level.
As used herein, and as will be generally understood by those skilled in the art, a first work function is "greater than" or "higher than" a second work function if the first work function has a higher absolute value. Since the work function is typically measured as negative relative to the vacuum level, this means that the "higher" work function is more negative (more negative). On a conventional energy level diagram with vacuum level at the top, the "higher" work function is illustrated as being farther from the vacuum level in the downward direction. Thus, the definitions of HOMO and LUMO energy levels follow a different rule than work functions.
The terms "halo," "halogen," and "halo" are used interchangeably and refer to fluorine, chlorine, bromine, and iodine.
The term "acyl" refers to a substituted carbonyl group (C (O) -Rs)。
The term "ester" refers to a substituted oxycarbonyl group (-O-C (O) -R)sor-C (O) -O-Rs) A group.
The term "ether" means-ORsA group.
The terms "thio" or "thioether" are used interchangeably and refer to-SRsA group.
The term "sulfinyl" refers to-S (O) -RsA group.
The term "sulfonyl" refers to-SO2-RsA group.
The term "phosphino" refers to-P (R)s)3Group, wherein each RsMay be the same or different.
The term "silyl" refers to-Si (R)s)3Group, wherein each RsMay be the same or different.
The term "oxyboronyl" refers to-B (R)s)2Group or Lewis adduct thereof (R) -B (R)s)3Group, wherein RsMay be the same or different.
In each of the above, RsMay be hydrogen or a substituent selected from the group consisting of: deuterium, halo, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, and combinations thereof. Preferred RsSelected from the group consisting of: alkyl, cycloalkyl, aryl, heteroaryl, and combinations thereof.
The term "alkyl" refers to and includes straight and branched chain alkyl groups. Preferred alkyl groups are those containing from one to fifteen carbon atoms and include methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1-dimethylpropyl, 1, 2-dimethylpropyl, 2-dimethylpropyl, and the like. In addition, the alkyl group may be optionally substituted.
The term "cycloalkyl" refers to and includes monocyclic, polycyclic and spiroalkyl groups. Preferred cycloalkyl groups are those containing 3 to 12 ring carbon atoms and include cyclopropyl, cyclopentyl, cyclohexyl, bicyclo [3.1.1] heptyl, spiro [4.5] decyl, spiro [5.5] undecyl, adamantyl, and the like. In addition, the cycloalkyl group may be optionally substituted.
The term "heteroalkyl" or "heterocycloalkyl" refers to an alkyl or cycloalkyl group, respectively, having at least one carbon atom replaced with a heteroatom. Optionally, the at least one heteroatom is selected from O, S, N, P, B, Si and Se, preferably O, S or N. In addition, heteroalkyl or heterocycloalkyl groups may be optionally substituted.
The term "alkenyl" refers to and includes straight and branched chain alkenyl groups. An alkenyl group is essentially an alkyl group that includes at least one carbon-carbon double bond in the alkyl chain. Cycloalkenyl is essentially cycloalkyl that includes at least one carbon-carbon double bond in the cycloalkyl ring. The term "heteroalkenyl" as used herein refers to an alkenyl group having at least one carbon atom replaced with a heteroatom. Optionally, the at least one heteroatom is selected from O, S, N, P, B, Si and Se, preferably O, S or N. Preferred alkenyl, cycloalkenyl or heteroalkenyl groups are those containing from two to fifteen carbon atoms. In addition, the alkenyl, cycloalkenyl or heteroalkenyl groups may be optionally substituted.
The term "alkynyl" refers to and includes straight and branched chain alkynyl groups. Alkynyl is essentially an alkyl group comprising at least one carbon-carbon triple bond in the alkyl chain. Preferred alkynyl groups are those containing from two to fifteen carbon atoms. In addition, alkynyl groups may be optionally substituted.
The terms "aralkyl" or "arylalkyl" are used interchangeably and refer to an alkyl group substituted with an aryl group. In addition, the aralkyl group may be optionally substituted.
The term "heterocyclyl" refers to and includes both aromatic and non-aromatic cyclic groups containing at least one heteroatom. Optionally, the at least one heteroatom is selected from O, S, N, P, B, Si and Se, preferably O, S or N. Aromatic heterocyclic groups may be used interchangeably with heteroaryl groups. Preferred non-aromatic heterocyclic groups are heterocyclic groups containing 3 to 7 ring atoms including at least one heteroatom and include cyclic amines such as morpholinyl, piperidinyl, pyrrolidinyl and the like, and cyclic ethers/thioethers such as tetrahydrofuran, tetrahydropyran, tetrahydrothiophene and the like. In addition, the heterocyclic group may be optionally substituted.
The term "aryl" refers to and includes monocyclic aromatic hydrocarbon radicals and polycyclic aromatic ring systems. Polycyclic rings can have two or more rings in which two carbons are common to two adjoining rings (the rings are "fused"), wherein at least one of the rings is an aromatic hydrocarbyl, e.g., the other rings can be cycloalkyls, cycloalkenyls, aryls, heterocyclics, and/or heteroaryls. Preferred aryl groups are those containing from six to thirty carbon atoms, preferably from six to twenty carbon atoms, more preferably from six to twelve carbon atoms. Especially preferred are aryl groups having six carbons, ten carbons, or twelve carbons. Suitable aryl groups include phenyl, biphenyl, terphenyl, triphenylene, tetraphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, perylene,
Figure BDA0002777829770000051
Perylene and azulene, preferably phenyl, biphenyl, terphenyl, triphenylene, fluorene and naphthalene. In addition, the aryl group may be optionally substituted.
The term "heteroaryl" refers to and includes monocyclic aromatic groups and polycyclic aromatic ring systems that include at least one heteroatom. Heteroatoms include, but are not limited to O, S, N, P, B, Si and Se. In many cases O, S or N are preferred heteroatoms. Monocyclic heteroaromatic systems are preferably monocyclic with 5 or 6 ring atoms, and rings may have one to six heteroatoms. A heteropolycyclic system can have two or more rings in which two atoms are common to two adjoining rings (the rings are "fused"), wherein at least one of the rings is heteroaryl, e.g., the other rings can be cycloalkyls, cycloalkenyls, aryls, heterocycles and/or heteroaryls. The heterocyclic aromatic ring system may have one to six heteroatoms per ring of the polycyclic aromatic ring system. Preferred heteroaryl groups are those containing from three to thirty carbon atoms, preferably from three to twenty carbon atoms, more preferably from three to twelve carbon atoms. Suitable heteroaryl groups include dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolobipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indolizine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furobipyridine, benzothienopyridine, thienobipyridine, benzothienopyridine, and selenenopyridine, preferably dibenzothiophene, and benzothiophene, Dibenzofurans, dibenzoselenophenes, carbazoles, indolocarbazoles, imidazoles, pyridines, triazines, benzimidazoles, 1, 2-azaborines, 1, 3-azaborines, 1, 4-azaborines, borazines, and aza analogs thereof. In addition, the heteroaryl group may be optionally substituted.
Of the aryl and heteroaryl groups listed above, triphenylene, naphthalene, anthracene, dibenzothiophene, dibenzofuran, dibenzoselenophene, carbazole, indolocarbazole, imidazole, pyridine, pyrazine, pyrimidine, triazine, and benzimidazole are of particular interest, as well as their respective corresponding aza analogues.
The terms alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aralkyl, heterocyclyl, aryl, and heteroaryl, as used herein, are independently unsubstituted or independently substituted with one or more general substituents.
In many cases, typical substituents are selected from the group consisting of: deuterium, halo, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, borinyl, and combinations thereof.
In some cases, preferred general substituents are selected from the group consisting of: deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, thio, oxyboronyl, and combinations thereof.
In some cases, more preferred general substituents are selected from the group consisting of: deuterium, fluorine, alkyl, cycloalkyl, alkoxy, aryloxy, amino, silyl, oxyboronyl, aryl, heteroaryl, thio, and combinations thereof.
In other cases, most preferred general substituents are selected from the group consisting of: deuterium, fluoro, alkyl, cycloalkyl, aryl, heteroaryl, and combinations thereof.
The terms "substituted" and "substitution" mean that a substituent other than H is bonded to the relevant position, e.g., carbon or nitrogen. For example, when R is1When representing a single substitution, then one R1Must not be H (i.e., substituted). Similarly, when R is1When representing disubstituted, then two R1Must not be H. Similarly, when R is1When represents zero or no substitution, R1For example, it may be hydrogen of available valency for the ring atoms, such as the carbon atom of benzene and the nitrogen atom of pyrrole, or it may be hydrogen of only zero for ring atoms having fully saturated valency, such as the nitrogen atom of pyridine. The maximum number of substitutions possible in a ring structure will depend on the total number of available valences in the ring atoms.
As used herein, "a combination thereof" means that one or more members of the applicable list are combined to form a known or chemically stable arrangement that one of ordinary skill in the art can envision from the applicable list. For example, alkyl and deuterium can be combined to form a partially or fully deuterated alkyl; halogen and alkyl may combine to form haloalkyl substituents; and halogen, alkyl, and aryl groups may be combined to form haloaralkyl groups. In one example, the term substituted includes combinations of two to four of the listed groups. In another example, the term substitution includes a combination of two to three groups. In yet another example, the term substitution includes a combination of two groups. Preferred combinations of substituents are those containing up to fifty atoms other than hydrogen or deuterium, or those containing up to forty atoms other than hydrogen or deuterium, or those containing up to thirty atoms other than hydrogen or deuterium. In many cases, a preferred combination of substituents will include up to twenty atoms that are not hydrogen or deuterium.
The term "aza" in the fragment described herein, i.e., aza-dibenzofuran, aza-dibenzothiophene, etc., means that one or more of the C-H groups in the corresponding aromatic ring can be replaced by a nitrogen atom, for example and without any limitation, azatriphenylene encompasses dibenzo [ f, H ] quinoxaline and dibenzo [ f, H ] quinoline. Other nitrogen analogs of the aza-derivatives described above can be readily envisioned by one of ordinary skill in the art, and all such analogs are intended to be encompassed by the term as set forth herein.
As used herein, "deuterium" refers to an isotope of hydrogen. Deuterated compounds can be readily prepared using methods known in the art. For example, U.S. patent No. 8,557,400, patent publication No. WO 2006/095951, and U.S. patent application publication No. US 2011/0037057 (which are incorporated herein by reference in their entirety) describe the preparation of deuterium substituted organometallic complexes. With further reference to \37154min (Ming Yan) et al, Tetrahedron (Tetrahedron)2015,71,1425-30 and azrote (Atzrodt) et al, german applied chemistry (angelw. chem. int. ed.) (review) 2007,46,7744-65, which are incorporated by reference in their entirety, describe efficient routes for deuteration of methylene hydrogens in benzylamines and replacement of aromatic ring hydrogens with deuterium, respectively.
It is understood that when a molecular fragment is described as a substituent or otherwise attached to another moiety, its name can be written as if it were a fragment (e.g., phenyl, phenylene, naphthyl, dibenzofuranyl) or as if it were an entire molecule (e.g., benzene, naphthalene, dibenzofuran). As used herein, these different named substituents or the manner of linking the fragments are considered equivalent.
In some cases, a pair of adjacent substituents may optionally join or be fused to form a ring. Preferred rings are five-, six-or seven-membered carbocyclic or heterocyclic rings, including both cases where a portion of the ring formed by the pair of substituents is saturated and where a portion of the ring formed by the pair of substituents is unsaturated. As used herein, "adjacent" means that the two substituents involved can be on the same ring next to each other, or on two adjacent rings having two nearest available substitutable positions (e.g., the 2,2' positions in biphenyl or the 1, 8 positions in naphthalene), so long as they can form a stable fused ring system.
B. Compounds of the present disclosure
In one aspect, the present disclosure provides
A compound comprising the structure of formula I
Figure BDA0002777829770000081
Wherein: y isiIs that
Figure BDA0002777829770000082
And Y isjIs that
Figure BDA0002777829770000083
Wherein:
RA、RB、RCand RDEach independently represents zero substitution, mono-substitution, di-substitution, or the maximum permissible substitution;
each RA、RB、RCAnd RDIndependently hydrogen or a substituent selected from the group consisting of the general substituents defined herein;
RA、RB、RCand RDComprises a carbazole moiety;
X1-X16each of which is independently C or N; and is
Any two substituents can be joined or fused together to form a ring.
In one aspect, each RA、RB、RCAnd RDIndependently hydrogen or a substituent selected from the group consisting of the preferred general substituents defined above.
In one aspect, each RA、RB、RCAnd RDIndependently hydrogen or deuterium.
In one aspect, RA、RB、RCAnd RDComprises a carbazole group.
In one aspect, RA、RB、RCAnd RDAre joined together to form a fused 5-or 6-membered carbocyclic or heterocyclic ring.
In one aspect, X1-X16Is N.
In one aspect, X1-X16Is C.
In one aspect, YiSelected from the group consisting of:
Figure BDA0002777829770000091
in one aspect, YiSelected from the group consisting of Y1-Y36Group of and YjSelected from the group consisting of Y1-Y43Group of (A) wherein Y1-Y43Has the following structure:
Figure BDA0002777829770000101
Figure BDA0002777829770000111
Figure BDA0002777829770000121
Figure BDA0002777829770000131
in one aspect, the compound of formula I is selected from the group consisting of:
Figure BDA0002777829770000132
Figure BDA0002777829770000141
Figure BDA0002777829770000151
Figure BDA0002777829770000161
Figure BDA0002777829770000171
Figure BDA0002777829770000181
Figure BDA0002777829770000191
C. OLEDs and devices of the present disclosure
In another aspect, the present disclosure also provides an OLED comprising a first organic layer comprising a compound disclosed in the above compounds section of the present disclosure.
In some embodiments, in one aspect, the first organic layer may further comprise a second compound comprising a chemical structure selected from the group consisting of: triazines, pyrimidines, pyridine, 9-dioxa-13 b-boranaphtho [3,2,1-de ] anthracene, azanaphthalene, azafluorene, azatriphenylene, azacarbazole, azaindolocarbazole, azadibenzothiophene, azadibenzofuran, and azadibenzoselenophene, as well as aza- (5, 9-dioxa-13 b-boranaphtho [3,2,1-de ] anthracene).
In one aspect, the present disclosure provides that the second compound is selected from the group consisting of:
Figure BDA0002777829770000192
wherein
K1'Is O or S;
K2'、K3'and K4'Is N or CR9
K5'Selected from the group consisting of O, S and NR10A group of compounds; and is
R1、R2、R3、R4、R5、R6、R7、R8、R9And R10Independently hydrogen or a substituent selected from the group consisting of: deuterium, halo, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, oxyboronyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, and combinations thereof.
In one aspect, the present disclosure provides that the second compound is selected from the group consisting of:
Figure BDA0002777829770000201
Figure BDA0002777829770000211
in one aspect, the first organic layer in the OLED can further comprise a compound of formula II
Figure BDA0002777829770000221
Wherein
M' is Pt or Pd;
rings a ', B', C 'and D' each independently represent a 5-or 6-membered carbocyclic or heterocyclic ring;
X1'-X12'each independently selected from the group consisting of carbon and nitrogen;
RA'、RB'、RC'and RD'Each independently represents mono-to the maximum allowed number of substitutions or no substitution;
each RA'、RB'、RC'And RD'Independently hydrogen or a substituent selected from the group consisting of: deuterium, halo, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, oxyboronyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, and combinations thereof;
n' is 0 or 1;
L1'、L2'and L3'Each independently selected from the group consisting of: direct bond, BRR', NR, PR, O, S, Se, C-O, S-O, SO2CRR ', SiRR ', GeRR ', and combinations thereof;
when n' is 1, L4'Selected from the group consisting of: direct bond, BRR', NR, PR, O, S, Se, C-O, S-O, SO2CRR ', SiRR ', GeRR ', and combinations thereof;
when n' is 0, L4'Is absent;
each Y is1'、Y2'、Y3'And Y4'Selected from the group consisting of a direct bond, O, and S;
wherein Y is1'、Y2'、Y3'And Y4'At least two of which are direct bonds.
In one aspect, the present disclosure provides that the compound of formula II in the first organic layer is a tetradentate Pt complex having at least one portion of a ligand selected from the group consisting of:
Figure BDA0002777829770000231
wherein each Y1To Y13Independently selected from the group consisting of carbon and nitrogen;
wherein Y' is selected from the group consisting of: b Re、N Re、P Re、O、S、Se、C=O、S=O、SO2、CReRf、SiReRfAnd GeReRf
Wherein R iseAnd RfOptionally fused or joined to form a ring;
wherein each Ra、Rb、RcAnd RdMay independently represent a single substituent up to the maximum possible number of substitutions, or no substitution;
wherein each Ra、Rb、Rc、Rd、ReAnd RfIndependently selected from the group consisting of: hydrogen, deuterium, halo, alkyl, cycloalkyl, heteroalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, and combinations thereof; and is
Wherein R isa、Rb、RcAnd RdAny two adjacent substituents of (a) are optionally fused or joined to form a ring.
In one aspect, the present disclosure provides that the compound of formula II in the first organic layer is selected from the group consisting of:
Figure BDA0002777829770000241
Figure BDA0002777829770000251
wherein L is selected from the group consisting of: o, S, Se, NR, BR, BRR ', C-O, S-O, CRR ', SiRR ', and combinations thereof; and is
Each RA、RB、RC、RD、REAnd RFIndependently hydrogen or a substituent selected from the group consisting of: deuterium, halo, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, oxyboronyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, and combinations thereof.
In some embodiments, the first organic layer may be an emissive layer and the compound as described herein may be an emissive dopant or a non-emissive dopant.
In some embodiments, the compound can be a fluorescent emitter.
In some embodiments, the first organic layer may further comprise a phosphorescent sensitizer, and the compound is a fluorescent acceptor.
In some embodiments, the OLED may comprise a second organic layer disposed between the anode and the cathode, wherein the second organic layer comprises a phosphorus photosensitizer and the compound is a fluorescence acceptor.
In some embodiments, the phosphorescent sensitizer is a transition metal complex having at least one ligand selected from the group consisting of:
Figure BDA0002777829770000261
Figure BDA0002777829770000271
wherein each Y1To Y13Each independently selected from the group consisting of carbon and nitrogen; y' is selected from the group consisting of: BR (BR)e、NRe、PRe、O、S、Se、C=O、S=O、SO2、CReRf、SiReRfAnd GeReRf;ReAnd RfOptionally fused or joined to form a ring; each Ra、Rb、RcAnd RdIndependently represent zero, single, or up to the maximum permissible substitutions for their consecutive rings; ra、Rb、Rc、Rd、ReAnd RfEach independently is hydrogen or a substituent selected from the group consisting of: deuterium, halo, alkyl, cycloalkyl, heteroalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, and combinations thereof; and R isa、Rb、RcAnd RdMay optionally be fused or joined to form a ring or form a multidentate ligand.
In some embodiments, one or more organic layers disposed between an anode and a cathode comprise a host, wherein the host comprises at least one chemical group selected from the group consisting of: anthracene, naphthalene, triphenylene, carbazole, dibenzothiophene, dibenzofuran, dibenzoselenophene, azatriphenylene, azacarbazole, aza-dibenzothiophene, aza-dibenzofuran, and aza-dibenzoselenophene.
In some embodiments, the subject may be selected from the group of subjects consisting of:
Figure BDA0002777829770000272
Figure BDA0002777829770000281
Figure BDA0002777829770000291
Figure BDA0002777829770000292
and combinations thereof.
In yet another aspect, the OLEDs of the present disclosure can further comprise an emissive region comprising a compound as disclosed in the above compounds section of the present disclosure.
In some embodiments, the emissive region can comprise a compound comprising the structure of formula I
Figure BDA0002777829770000293
Wherein: y isiIs that
Figure BDA0002777829770000294
And Y isjIs that
Figure BDA0002777829770000295
Wherein:
RA、RB、RCand RDEach independently represents zero substitution, mono-substitution, di-substitution, or the maximum permissible substitution;
each RA、RB、RCAnd RDIndependently hydrogen or a substituent selected from the group consisting of the general substituents defined herein;
RA、RB、RCand RDComprises a carbazole moiety;
X1-X16each of which is independently C or N; and is
Any two substituents can be joined or fused together to form a ring.
In yet another aspect, the present disclosure also provides a consumer product comprising an Organic Light Emitting Device (OLED) having an anode; a cathode; and an organic layer disposed between the anode and the cathode, wherein the organic layer can comprise a compound as disclosed in the compounds section of the disclosure above.
In some embodiments, a consumer product includes an Organic Light Emitting Device (OLED) having an anode; a cathode; and an organic layer disposed between the anode and the cathode, wherein the organic layer can comprise a compound comprising a structure of formula I
Figure BDA0002777829770000301
Wherein: y isiIs that
Figure BDA0002777829770000302
And Y isjIs that
Figure BDA0002777829770000303
Wherein:
RA、RB、RCand RDEach independently represents zero substitution, mono-substitution, di-substitution, or the maximum permissible substitution;
each RA、RB、RCAnd RDIndependently hydrogen or a substituent selected from the group consisting of the general substituents defined herein;
RA、RB、RCand RDComprises a carbazole moiety;
X1-X16each of which is independently C or N; and is
Any two substituents can be joined or fused together to form a ring.
In some embodiments, the consumer product may be one of the following: a flat panel display, a computer monitor, a medical monitor, a television, a billboard, a light for interior or exterior lighting and/or signaling, a heads-up display, a fully or partially transparent display, a flexible display, a laser printer, a telephone, a cellular telephone, a tablet, a phablet, a Personal Digital Assistant (PDA), a wearable device, a laptop computer, a digital camera, a video camera, a viewfinder, a microdisplay at a diagonal of less than 2 inches, a 3-D display, a virtual reality or augmented reality display, a vehicle, a video wall containing multiple displays tiled together, a theater or stadium screen, a phototherapy device, and a sign.
Generally, an OLED comprises at least one organic layer disposed between and electrically connected to an anode and a cathode. When current is applied, the anode injects holes and the cathode injects electrons into the organic layer. The injected holes and electrons each migrate toward the oppositely charged electrode. When an electron and a hole are located on the same molecule, an "exciton," which is a localized electron-hole pair with an excited energy state, is formed. When the exciton relaxes by a light emission mechanism, light is emitted. In some cases, the exciton may be localized on an excimer (eximer) or an exciplex. Non-radiative mechanisms (such as thermal relaxation) may also occur, but are generally considered undesirable.
Several OLED materials and configurations are described in U.S. patent nos. 5,844,363, 6,303,238, and 5,707,745, which are incorporated herein by reference in their entirety.
The initial OLEDs used emissive molecules that emit light from a singlet state ("fluorescence"), as disclosed, for example, in U.S. patent No. 4,769,292, which is incorporated by reference in its entirety. Fluorescence emission typically occurs in a time frame of less than 10 nanoseconds.
More recently, OLEDs having emissive materials that emit light from the triplet state ("phosphorescence") have been demonstrated. Baldo et al, "high efficiency Phosphorescent Emission from Organic Electroluminescent Devices" (Nature), 395, 151-154,1998 ("Baldo-I"); and baldo et al, "Very high-efficiency green organic light-emitting devices based on electrophosphorescence (Very high-efficiency green organic light-emitting devices-based on electrophosphorescence)", applied physical promo (appl. phys. lett.), volume 75, stages 3,4-6 (1999) ("baldo-II"), which are incorporated by reference in their entirety. Phosphorescence is described in more detail in U.S. Pat. No. 7,279,704, columns 5-6, which is incorporated by reference.
Fig. 1 shows an organic light emitting device 100. The figures are not necessarily to scale. Device 100 can include substrate 110, anode 115, hole injection layer 120, hole transport layer 125, electron blocking layer 130, emissive layer 135, hole blocking layer 140, electron transport layer 145, electron injection layer 150, protective layer 155, cathode 160, and blocking layer 170. Cathode 160 is a composite cathode having a first conductive layer 162 and a second conductive layer 164. The device 100 may be fabricated by depositing the layers in sequence. The nature and function of these various layers, as well as example materials, are described in more detail in U.S. Pat. No. 7,279,704, columns 6-10, which is incorporated by reference.
More instances of each of these layers are available. For example, a flexible and transparent substrate-anode combination is disclosed in U.S. Pat. No. 5,844,363, which is incorporated by reference in its entirety. An example of a p-doped hole transport layer is doped with F at a molar ratio of 50:14TCNQ m-MTDATA as disclosed in U.S. patent application publication No. 2003/0230980, which is incorporated by reference in its entirety. Examples of emissive and host materials are disclosed in U.S. patent No. 6,303,238 to Thompson et al, which is incorporated by reference in its entirety. An example of an n-doped electron transport layer is BPhen doped with Li at a molar ratio of 1:1, as disclosed in U.S. patent application publication No. 2003/0230980, which is incorporated by reference in its entirety. U.S. Pat. Nos. 5,703,436 and 5,707,745, which are incorporated by reference in their entirety, disclose examples of cathodes comprising composite cathodes having a thin layer of a metal (e.g., Mg: Ag) with an overlying transparent, conductive, sputter-deposited ITO layer. The theory and use of the barrier layer is described in more detail inU.S. patent No. 6,097,147 and U.S. patent application publication No. 2003/0230980, which are incorporated by reference in their entirety. Examples of injection layers are provided in U.S. patent application publication No. 2004/0174116, which is incorporated by reference in its entirety. A description of the protective layer may be found in U.S. patent application publication No. 2004/0174116, which is incorporated by reference in its entirety.
Fig. 2 shows an inverted OLED 200. The device includes a substrate 210, a cathode 215, an emissive layer 220, a hole transport layer 225, and an anode 230. The device 200 may be fabricated by depositing the layers in sequence. Because the most common OLED configuration has a cathode disposed above an anode, and device 200 has a cathode 215 disposed below an anode 230, device 200 may be referred to as an "inverted" OLED. Materials similar to those described with respect to device 100 may be used in corresponding layers of device 200. Fig. 2 provides one example of how some layers may be omitted from the structure of device 100.
The simple layered structure illustrated in fig. 1 and 2 is provided by way of non-limiting example, and it is to be understood that embodiments of the present disclosure may be used in conjunction with various other structures. The specific materials and structures described are exemplary in nature, and other materials and structures may be used. Functional OLEDs may be obtained by combining the various layers described in different ways, or the layers may be omitted entirely based on design, performance, and cost factors. Other layers not specifically described may also be included. Materials other than those specifically described may be used. Although many of the examples provided herein describe the various layers as comprising a single material, it is understood that combinations of materials may be used, such as mixtures of hosts and dopants, or more generally, mixtures. Further, the layer may have various sub-layers. The names given to the various layers herein are not intended to be strictly limiting. For example, in device 200, hole transport layer 225 transports holes and injects holes into emissive layer 220, and may be described as a hole transport layer or a hole injection layer. In one embodiment, an OLED may be described as having an "organic layer" disposed between a cathode and an anode. This organic layer may comprise a single layer, or may further comprise multiple layers of different organic materials as described, for example, with respect to fig. 1 and 2.
Structures and materials not specifically described may also be used, such as oleds (pleds) comprising polymeric materials, such as disclosed in U.S. patent No. 5,247,190 to frand (Friend), et al, which is incorporated by reference in its entirety. By way of further example, OLEDs having a single organic layer may be used. The OLEDs may be stacked, for example, as described in U.S. patent No. 5,707,745 to forrister (Forrest) et al, which is incorporated by reference in its entirety. The OLED structure may deviate from the simple layered structure illustrated in fig. 1 and 2. For example, the substrate may include an angled reflective surface to improve out-coupling (out-coupling), such as a mesa structure as described in U.S. Pat. No. 6,091,195 to Foster et al, and/or a pit structure as described in U.S. Pat. No. 5,834,893 to Boolean (Bulovic) et al, which are incorporated by reference in their entirety.
Any of the layers of the various embodiments may be deposited by any suitable method, unless otherwise specified. For organic layers, preferred methods include thermal evaporation, ink jetting (as described in U.S. Pat. Nos. 6,013,982 and 6,087,196, both incorporated by reference in their entirety), organic vapor deposition (OVPD) (as described in U.S. Pat. No. 6,337,102 to Foster et al, both incorporated by reference in their entirety), and deposition by Organic Vapor Jet Printing (OVJP) (as described in U.S. Pat. No. 7,431,968, incorporated by reference in its entirety). Other suitable deposition methods include spin coating and other solution-based processes. The solution-based process is preferably carried out in a nitrogen or inert atmosphere. For other layers, a preferred method includes thermal evaporation. Preferred patterning methods include deposition through a mask, cold welding (as described in U.S. Pat. nos. 6,294,398 and 6,468,819, which are incorporated by reference in their entirety), and patterning associated with some of the deposition methods such as inkjet and Organic Vapor Jet Printing (OVJP). Other methods may also be used. The material to be deposited may be modified to suit the particular deposition method. For example, substituents such as alkyl and aryl groups, branched or unbranched, and preferably containing at least 3 carbons, may be used in small molecules to enhance their ability to undergo solution processing. Substituents having 20 carbons or more may be used, and 3 to 20 carbons is a preferred range. A material with an asymmetric structure may have better solution processibility than a material with a symmetric structure because asymmetric materials may have a lower tendency to recrystallize. Dendrimer substituents may be used to enhance the ability of small molecules to undergo solution processing.
Devices fabricated according to embodiments of the present disclosure may further optionally include a barrier layer. One use of barrier layers is to protect the electrodes and organic layers from damage from exposure to hazardous substances in the environment including moisture, vapor, and/or gas. The barrier layer may be deposited on, under or beside the substrate, electrode, or on any other part of the device, including the edge. The barrier layer may comprise a single layer or multiple layers. The barrier layer may be formed by various known chemical vapor deposition techniques and may include compositions having a single phase and compositions having multiple phases. Any suitable material or combination of materials may be used for the barrier layer. The barrier layer may incorporate an inorganic compound or an organic compound or both. Preferred barrier layers comprise a mixture of polymeric and non-polymeric materials as described in U.S. patent No. 7,968,146, PCT patent application nos. PCT/US2007/023098 and PCT/US2009/042829, which are incorporated herein by reference in their entirety. To be considered a "mixture," the aforementioned polymeric and non-polymeric materials that make up the barrier layer should be deposited under the same reaction conditions and/or simultaneously. The weight ratio of polymeric material to non-polymeric material may be in the range of 95:5 to 5: 95. The polymeric material and the non-polymeric material may be produced from the same precursor material. In one example, the mixture of polymeric material and non-polymeric material consists essentially of polymeric silicon and inorganic silicon.
Devices manufactured according to embodiments of the present disclosure may be incorporated into a wide variety of electronic component modules (or units), which may be incorporated into a wide variety of electronic products or intermediate components. Examples of such electronic products or intermediate components include display screens, lighting devices (e.g., discrete light source devices or lighting panels), etc., which may be utilized by end-user product manufacturers. The electronics module may optionally include drive electronics and/or a power source. Devices manufactured in accordance with embodiments of the present disclosure may be incorporated into a wide variety of consumer products having one or more electronic component modules (or units) incorporated therein. A consumer product comprising an OLED comprising a compound of the present disclosure in an organic layer in the OLED is disclosed. The consumer product shall include any kind of product comprising one or more light sources and/or one or more of some type of visual display. Some examples of such consumer products include flat panel displays, curved displays, computer monitors, medical monitors, televisions, billboards, lights for interior or exterior illumination and/or signaling, heads-up displays, fully or partially transparent displays, flexible displays, rollable displays, foldable displays, stretchable displays, laser printers, telephones, cellular telephones, tablet computers, tablet phones, Personal Digital Assistants (PDAs), wearable devices, laptop computers, digital cameras, video cameras, viewfinders, microdisplays (displays less than 2 inches diagonal), 3-D displays, virtual reality or augmented reality displays, vehicles, video walls containing multiple displays tiled together, theater or stadium screens, phototherapy devices, and signs. Various control mechanisms may be used to control devices made in accordance with the present disclosure, including passive matrices and active matrices. Many of the devices are intended to be used in a temperature range that is comfortable for humans, such as 18 ℃ to 30 ℃, and more preferably at room temperature (20-25 ℃), but can be used outside this temperature range (e.g., -40 ℃ to +80 ℃).
More details regarding OLEDs and the definitions described above can be found in U.S. patent No. 7,279,704, which is incorporated herein by reference in its entirety.
The materials and structures described herein may be applied to devices other than OLEDs. For example, other optoelectronic devices such as organic solar cells and organic photodetectors may employ the materials and structures. More generally, organic devices such as organic transistors may employ the materials and structures.
In some embodiments, the OLED has one or more features selected from the group consisting of: flexible, rollable, foldable, stretchable, and bendable. In some embodiments, the OLED is transparent or translucent. In some embodiments, the OLED further comprises a layer comprising carbon nanotubes.
In some embodiments, the OLED further comprises a layer comprising a delayed fluorescence emitter. In some embodiments, the OLED comprises an RGB pixel arrangement or a white plus color filter pixel arrangement. In some embodiments, the OLED is a mobile device, a handheld device, or a wearable device. In some embodiments, the OLED is a display panel having a diagonal of less than 10 inches or an area of less than 50 square inches. In some embodiments, the OLED is a display panel having a diagonal of at least 10 inches or an area of at least 50 square inches. In some embodiments, the OLED is a lighting panel.
In some embodiments, the compound may be an emissive dopant. In some embodiments, the compounds may produce emission via phosphorescence, fluorescence, thermally activated delayed fluorescence (i.e., TADF, also known as E-type delayed fluorescence, see, e.g., U.S. application No. 15/700,352, which is incorporated herein by reference in its entirety), triplet-triplet annihilation, or a combination of these processes. In some embodiments, the emissive dopant may be a racemic mixture, or may be enriched in one enantiomer. In some embodiments, the compounds may be homoleptic (each ligand is the same). In some embodiments, the compounds may be compounded (at least one ligand being different from the others). In some embodiments, when there is more than one ligand that coordinates to the metal, the ligands may all be the same. In some other embodiments, at least one ligand is different from the other ligands. In some embodiments, each ligand may be different from each other. This is also true in embodiments where the ligand that coordinates to the metal can be linked to other ligands that coordinate to the metal to form a tridentate, tetradentate, pentadentate, or hexadentate ligand. Thus, where coordinating ligands are linked together, in some embodiments, all of the ligands may be the same, and in some other embodiments, at least one of the ligands linked may be different from the other ligands.
In some embodiments, the compounds can be used as a component of an excited complex used as a sensitizer.
In some embodiments, the sensitizer is a single component, or one of the components, that forms the excited complex.
According to another aspect, a formulation comprising a compound described herein is also disclosed.
The OLEDs disclosed herein can be incorporated into one or more of consumer products, electronic component modules, and lighting panels. The organic layer may be an emissive layer, and the compound may be an emissive dopant in some embodiments, while the compound may be a non-emissive dopant in other embodiments.
In yet another aspect of the present invention, a formulation comprising the novel compound disclosed herein is described. The formulation may include one or more of the components disclosed herein selected from the group consisting of: a solvent, a host, a hole injection material, a hole transport material, an electron blocking material, a hole blocking material, and an electron transport material.
The present disclosure encompasses any chemical structure comprising the novel compounds of the present disclosure or monovalent or multivalent variants thereof. In other words, the compounds of the present invention or monovalent or multivalent variants thereof may be part of a larger chemical structure. Such chemical structures may be selected from the group consisting of: monomers, polymers, macromolecules and supramolecules (also known as supramolecules). As used herein, "monovalent variant of a compound" refers to a moiety that is the same as a compound but where one hydrogen has been removed and replaced with a bond to the remainder of the chemical structure. As used herein, "multivalent variants of a compound" refers to moieties that are the same as a compound but where more than one hydrogen has been removed and replaced with one or more bonds to the rest of the chemical structure. In the case of supramolecules, the compounds of the invention may also be incorporated into supramolecular complexes without covalent bonds.
D. Combinations of the compounds of the present disclosure with other materials
Materials described herein as suitable for use in a particular layer in an organic light emitting device can be used in combination with a variety of other materials present in the device. For example, the emissive dopants disclosed herein may be used in conjunction with a wide variety of hosts, transport layers, barrier layers, implant layers, electrodes, and other layers that may be present. The materials described or referenced below are non-limiting examples of materials that can be used in combination with the compounds disclosed herein, and one of ordinary skill in the art can readily review the literature to identify other materials that can be used in combination.
a) Conductive dopant:
the charge transport layer may be doped with a conductivity dopant to substantially change its charge carrier density, which in turn will change its conductivity. The conductivity is increased by the generation of charge carriers in the host material and, depending on the type of dopant, a change in the Fermi level of the semiconductor can also be achieved. The hole transport layer may be doped with a p-type conductivity dopant and an n-type conductivity dopant is used in the electron transport layer.
Non-limiting examples of conductivity dopants that can be used in OLEDs in combination with the materials disclosed herein, along with references disclosing those materials, are exemplified below: EP01617493, EP01968131, EP2020694, EP2684932, US20050139810, US20070160905, US20090167167, US2010288362, WO06081780, WO2009003455, WO2009008277, WO2009011327, WO2014009310, US2007252140, US2015060804, US20150123047 and US 2012146012.
Figure BDA0002777829770000361
Figure BDA0002777829770000371
b)HIL/HTL:
The hole injection/transport material used in the present disclosure is not particularly limited, and any compound may be used as long as the compound is generally used as the hole injection/transport material. Examples of materials include (but are not limited to): phthalocyanine or porphyrin derivatives; an aromatic amine derivative; indolocarbazole derivatives; a fluorocarbon-containing polymer; a polymer having a conductive dopant; conductive polymers such as PEDOT/PSS; self-assembling monomers derived from compounds such as phosphonic acids and silane derivatives; metal oxide derivatives, e.g. MoOx(ii) a p-type semiconducting organic compounds, such as 1,4,5,8,9, 12-hexaazatriphenylhexacyano-nitrile; a metal complex; and a crosslinkable compound.
Examples of aromatic amine derivatives for use in HILs or HTLs include, but are not limited to, the following general structures:
Figure BDA0002777829770000372
Ar1to Ar9Each of which is selected from: a group consisting of aromatic hydrocarbon cyclic compounds such as: benzene, biphenyl, terphenyl, triphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene,
Figure BDA0002777829770000373
Perylene and azulene; a group consisting of aromatic heterocyclic compounds such as: dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolobipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indolizine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyranePyridine, furobipyridine, benzothienopyridine, thienobipyridine, benzoselenophenopyridine, and selenophenodipyridine; and a group consisting of 2 to 10 cyclic structural units which are the same type or different types of groups selected from aromatic hydrocarbon ring groups and aromatic heterocyclic groups and are bonded to each other directly or via at least one of an oxygen atom, a nitrogen atom, a sulfur atom, a silicon atom, a phosphorus atom, a boron atom, a chain structural unit and an aliphatic ring group. Each Ar may be unsubstituted or may be substituted with a substituent selected from the group consisting of: deuterium, halo, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, and combinations thereof.
In one aspect, Ar1To Ar9Independently selected from the group consisting of:
Figure BDA0002777829770000381
wherein k is an integer from 1 to 20; x101To X108Is C (including CH) or N; z101Is NAr1O or S; ar (Ar)1Having the same groups as defined above.
Examples of metal complexes used in HILs or HTLs include, but are not limited to, the following general formulas:
Figure BDA0002777829770000382
wherein Met is a metal which may have an atomic weight greater than 40; (Y)101-Y102) Is a bidentate ligand, Y101And Y102Independently selected from C, N, O, P and S; l is101Is an ancillary ligand; k' is an integer value from 1 to the maximum number of ligands that can be attached to the metal; and k' + k "is the maximum number of ligands that can be attached to the metal.
In one aspect, (Y)101-Y102) Is a 2-phenylpyridine derivative. In another aspect, (Y)101-Y102) Is a carbene ligand. In another aspect, Met is selected from Ir, Pt, Os and Zn. In another aspect, the metal complex has a structure comparable to Fc+A minimum oxidation potential in solution of less than about 0.6V for/Fc coupling.
Non-limiting examples of HIL and HTL materials that can be used in OLEDs in combination with the materials disclosed herein, along with references disclosing those materials, are exemplified by the following: CN102702075, DE102012005215, EP01624500, EP0169861, EP01806334, EP01930964, EP01972613, EP01997799, EP02011790, EP02055700, EP02055701, EP1725079, EP2085382, EP2660300, EP650955, JP07-073529, JP2005112765, JP2007091, JP 2008021621687, JP2014-009196, KR 201188898, KR20130077473, TW 201139201139402, US06517957, US 2008220158242, US20030162053, US20050123751 751, US 20060282993, US 200602872 14579, US 201181874874, US20070278938, US 20080014014464 091091091, US20080106190, US 200907192605092385, US 12460352009071794392604335200356371798, WO 20120020120020135200353141563543544354435443544354435443544354435443544354435443544354435646, WO 200200352003520035563256325632563256325646, WO 20035200352003520035200435443544354435443544354435443544354435443544354435646, WO 200605646, WO 200605632563256325632563256325646, WO 2002002002002002002002002002002002002002004356325632563256325632563256325632563256325632563256325632563256325632567, WO 2004354435443435632563256325632563256325632563256325632563243544354434354435443544354435443544354435443544354435443541, WO 200200200200200200200200200200200200200200200200200200.
Figure BDA0002777829770000391
Figure BDA0002777829770000401
Figure BDA0002777829770000411
Figure BDA0002777829770000421
Figure BDA0002777829770000431
Figure BDA0002777829770000441
Figure BDA0002777829770000451
c)EBL:
An Electron Blocking Layer (EBL) may be used to reduce the number of electrons and/or excitons that leave the emissive layer. The presence of such a barrier layer in a device may result in substantially higher efficiency and/or longer lifetime compared to a similar device lacking a barrier layer. In addition, blocking layers can be used to limit the emission to the desired area of the OLED. In some embodiments, the EBL material has a higher LUMO (closer to the vacuum level) and/or higher triplet energy than the emitter closest to the EBL interface. In some embodiments, the EBL material has a higher LUMO (closer to the vacuum level) and/or higher triplet energy than one or more of the bodies closest to the EBL interface. In one aspect, the compound used in the EBL contains the same molecule or the same functional group as used in one of the hosts described below.
d) A main body:
the light-emitting layer of the organic EL device of the present disclosure preferably contains at least a metal complex as a light-emitting material, and may contain a host material using the metal complex as a dopant material. Examples of the host material are not particularly limited, and any metal complex or organic compound may be used as long as the triplet energy of the host is larger than that of the dopant. Any host material may be used with any dopant so long as the triplet criteria are met.
Examples of the metal complex used as the host preferably have the following general formula:
Figure BDA0002777829770000452
wherein Met is a metal; (Y)103-Y104) Is a bidentate ligand, Y103And Y104Independently selected from C, N, O, P and S; l is101Is another ligand; k' is an integer value from 1 to the maximum number of ligands that can be attached to the metal; and k' + k "is the maximum number of ligands that can be attached to the metal.
In one aspect, the metal complex is:
Figure BDA0002777829770000453
wherein (O-N) is a bidentate ligand having a metal coordinated to the O and N atoms.
In another aspect, Met is selected from Ir and Pt. In another aspect, (Y)103-Y104) Is a carbene ligand.
In one aspect, the host compound contains at least one selected from the group consisting of: a group consisting of aromatic hydrocarbon cyclic compounds such as: benzene, biphenyl, terphenyl, triphenylene, tetraphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, perylene,
Figure BDA0002777829770000461
Perylene and azulene; a group consisting of aromatic heterocyclic compounds such as: dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolobipyridine, pyrazole, imidazole, triazole, oxazoleThiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indolizine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furobipyridine, benzothienopyridine, thienobipyridine, benzoselenenopyridine, and selenenopyridine; and a group consisting of 2 to 10 cyclic structural units which are the same type or different types of groups selected from aromatic hydrocarbon ring groups and aromatic heterocyclic groups and are bonded to each other directly or via at least one of an oxygen atom, a nitrogen atom, a sulfur atom, a silicon atom, a phosphorus atom, a boron atom, a chain structural unit and an aliphatic ring group. Each option in each group may be unsubstituted or may be substituted with a substituent selected from the group consisting of: deuterium, halo, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, and combinations thereof.
In one aspect, the host compound contains at least one of the following groups in the molecule:
Figure BDA0002777829770000462
Figure BDA0002777829770000471
wherein R is101Selected from the group consisting of: hydrogen, deuterium, halo, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile,Thio, sulfinyl, sulfonyl, phosphino, and combinations thereof, and when it is aryl or heteroaryl, it has a similar definition as Ar mentioned above. k is an integer from 0 to 20 or from 1 to 20. X101To X108Independently selected from C (including CH) or N. Z101And Z102Independently selected from NR101O or S.
Non-limiting examples of host materials that can be used in OLEDs in combination with the materials disclosed herein are exemplified below, along with references disclosing those materials: EP2034538, EP2034538A, EP2757608, JP2007254297, KR20100079458, KR20120088644, KR20120129733, KR20130115564, TW201329200, US20030175553, US20050238919, US20060280965, US20090017330, US20090030202, US20090167162, US20090302743, US20090309488, US20100012931, US20100084966, US20100187984, US2010187984, US2012075273, US2012126221, US2013009543, US2013105787, US2013175519, US 001446, US 20148301503, US20140225088, US2014034914, US7154114, WO2001039234, WO 2004093203203203207, WO 2005014545454545452009020090455646, WO 2002012009020120090201902019072201200907220120020190722012002012002016072201200201200201200201607246, WO 20120020120020160722012002016072201200201200201607246, WO 200201200201200201200201200201200201200201200907220020120020120020120020120020120020120090729, WO 200201200201200201200201200201200201200201200201200201200201200201200201200201200201200201200201200200200201200201200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200,
Figure BDA0002777829770000481
Figure BDA0002777829770000491
Figure BDA0002777829770000501
Figure BDA0002777829770000511
Figure BDA0002777829770000521
e) other emitters:
one or more other emitter dopants may be used in combination with the compounds of the present invention. Examples of the other emitter dopant are not particularly limited, and any compound may be used as long as the compound is generally used as an emitter material. Examples of suitable emitter materials include, but are not limited to, compounds that can produce emission via phosphorescence, fluorescence, thermally activated delayed fluorescence (i.e., TADF, also known as E-type delayed fluorescence), triplet-triplet annihilation, or a combination of these processes.
Non-limiting examples of emitter materials that can be used in OLEDs in combination with the materials disclosed herein, along with references disclosing those materials, are exemplified below: CN103694277, CN1696137, EB01238981, EP01239526, EP01961743, EP1239526, EP1244155, EP1642951, EP1647554, EP1841834, EP1841834B, EP2062907, EP2730583, JP 201207440263, JP4478555, KR1020090133652, KR20120032054, KR20130043460, TW201332980, US0669959, US 200100916520, US20010019782, US20020034656, US 20030068568526, US20030072964, US 2003013865657, US 200501787878788, US 20020020020020120044673, US2005123791, US 2006052449 449, US20060008670, US20060065890, US 601696, US 6016016016012006012016016310204659, US 2012002012002012002012002012000477817781979, WO 20020120020120020120020020020020020020004778177819748, US 20120020020004779, WO 200200200201200201200200200200200201200778177819748, US 20020120004779, US 20120020120020120020120020020120020020020004779, US 2002012002002002002002002002002002002002002002002002002002012000477819748, US 200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200779, US 200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200779, US 200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200200779, US 20020020020020020020020020020020020020020020020020020020120020120020020020020020020020020020020020020020020020020020020020020020020043979, US 20020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020043979, US 20020020020020020020020020020020020020020020020020020020020020020020020020020020020043979, US 20020020020120020120020020020020020020020020020020020020020020020043979, US 20020020020020020020020020020020020120020120020020020020020020020020020020020020020020020020020020020020020020020020020020120020020020020020020020020020020020020020020020043979, US 20020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020020120020120020120020120043979, US 200200200200200200200200200200200200200200200200200200200200200200200200200200200, WO2012020327, WO2012163471, WO2013094620, WO2013107487, WO2013174471, WO2014007565, WO2014008982, WO2014023377, WO2014024131, WO2014031977, WO2014038456, WO 2014112450.
Figure BDA0002777829770000531
Figure BDA0002777829770000541
Figure BDA0002777829770000551
Figure BDA0002777829770000561
Figure BDA0002777829770000571
Figure BDA0002777829770000581
f)HBL:
Hole Blocking Layers (HBLs) may be used to reduce the number of holes and/or excitons that leave the emissive layer. The presence of such a barrier layer in a device may result in substantially higher efficiency and/or longer lifetime compared to a similar device lacking a barrier layer. In addition, blocking layers can be used to limit the emission to the desired area of the OLED. In some embodiments, the HBL material has a lower HOMO (farther from the vacuum level) and/or higher triplet energy than the emitter closest to the HBL interface. In some embodiments, the HBL material has a lower HOMO (farther from the vacuum level) and/or higher triplet energy than one or more of the hosts closest to the HBL interface.
In one aspect, the compound used in the HBL contains the same molecule or the same functional group as used for the host described above.
In another aspect, the compound used in HBL contains in the molecule at least one of the following groups:
Figure BDA0002777829770000582
wherein k is an integer from 1 to 20; l is101Is another ligand, and k' is an integer of 1 to 3.
g)ETL:
The Electron Transport Layer (ETL) may include a material capable of transporting electrons. The electron transport layer may be intrinsic (undoped) or doped. Doping may be used to enhance conductivity. Examples of the ETL material are not particularly limited, and any metal complex or organic compound may be used as long as it is generally used to transport electrons.
In one aspect, the compound used in the ETL contains in the molecule at least one of the following groups:
Figure BDA0002777829770000583
wherein R is101Selected from the group consisting of: hydrogen, deuterium, halo, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, and combinations thereof, when aryl or heteroaryl, have similar definitions as Ar described above. Ar (Ar)1To Ar3Have similar definitions as Ar mentioned above. k is an integer of 1 to 20. X101To X108Selected from C (including CH) or N.
In another aspect, the metal complex used in the ETL contains (but is not limited to) the following general formula:
Figure BDA0002777829770000591
wherein (O-N) or (N-N) is a bidentate ligand having a metal coordinated to atom O, N or N, N; l is101Is another ligand; k' is an integer value from 1 to the maximum number of ligands that can be attached to the metal.
Non-limiting examples of ETL materials that can be used in an OLED in combination with the materials disclosed herein, along with references disclosing those materials, are exemplified as follows: CN103508940, EP01602648, EP01734038, EP01956007, JP2004-022334, JP2005149918, JP2005-268199, KR0117693, KR20130108183, US20040036077, US20070104977, US2007018155, US20090101870, US20090115316, US20090140637, US 2009017959554, US2009218940, US2010108990, US2011156017, US2011210320, US2012193612, US2012214993, US 20140142014014925, US 201401492014927, US 2014028450284580, US 5666612, US 1508431, WO 200306093060979256, WO2007111263, WO2009148269, WO2010067894, WO2010072300, WO 201107070, WO 105373, WO 201303017, WO 201314545477, WO 2014545667, WO 201104376, WO2014104535, WO 2014535,
Figure BDA0002777829770000592
Figure BDA0002777829770000601
Figure BDA0002777829770000611
h) charge Generation Layer (CGL)
In tandem or stacked OLEDs, CGL plays a fundamental role in performance, consisting of an n-doped layer and a p-doped layer for injecting electrons and holes, respectively. Electrons and holes are supplied by the CGL and the electrodes. Electrons and holes consumed in the CGL are refilled by electrons and holes injected from the cathode and anode, respectively; subsequently, the bipolar current gradually reaches a steady state. Typical CGL materials include n and p conductivity dopants used in the transport layer.
In any of the above-mentioned compounds used in each layer of the OLED device, the hydrogen atoms may be partially or fully deuterated. Thus, any of the specifically listed substituents, such as (but not limited to) methyl, phenyl, pyridyl, and the like, can be in their non-deuterated, partially deuterated, and fully deuterated forms. Similarly, substituent classes (such as, but not limited to, alkyl, aryl, cycloalkyl, heteroaryl, etc.) can also be non-deuterated, partially deuterated, and fully deuterated forms thereof.
It should be understood that the various embodiments described herein are by way of example only and are not intended to limit the scope of the invention. For example, many of the materials and structures described herein may be substituted with other materials and structures without departing from the spirit of the invention. The invention as claimed may thus comprise variations of the specific examples and preferred embodiments described herein, as will be apparent to those skilled in the art. It should be understood that various theories as to why the invention works are not intended to be limiting.
E. Experimental data
Synthesis of 9- (2' - (9H-carbazol-9-yl) - [1,1' -biphenyl ] -2-yl) -9H-3,9' -bicarbazole (compound a):
Figure BDA0002777829770000621
step 1: A5L flask equipped with a magnetic stirrer, condenser and thermowell was charged with 9- (2-bromophenyl) -9H-carbazole (80g, 243mmol), (2-fluorophenyl) boronic acid (42.1g, 292mmol), sodium carbonate (59.3g, 560mmol), 1, 2-dimethoxyethane (1569ml) and water (157 ml). The resulting mixture was degassed with nitrogen for 20 minutes. Addition of Pd (PPh)3)4(14.06g, 12.17mmol) and degassed with nitrogen for 20 minutes. The reaction mixture was heated to 78 ℃ and stirred for 24 hours. The mixture was cooled to room temperature, the two layers were separated, and the aqueous layer was extracted with Dichloromethane (DCM). The combined organic layers were concentrated, the resulting crude residue was dissolved in 2L toluene and filtered through a pad of silica. Fractions containing compound were combined and concentrated. The resulting gum was wet-milled with heptane to give a suspension which, after filtration, gave 9- (2 '-fluoro- [1,1' -biphenyl as a white solid]-2-yl) -9H-carbazole (54.4 g; 66.3% yield).
Step 2: A2L flask equipped with a mechanical stirrer, condenser and thermowell was charged with 9- (2' -fluoro- [1,1' -biphenyl ] -2-yl) -9H-carbazole (53g, 157mmol), 9H-3,9' -dicarbazole (94g, 283mmol), potassium phosphate (167g, 785mmol), NMP (262ml) and stirred at 203 ℃ for 24 hours. The reaction mixture was cooled to room temperature and added to water (3L) at 10 ℃. The resulting solid was filtered, washed with water and dried. The solid was then wet-milled in methanol and DCM/methanol refluxed to give 9- (2' - (9H-carbazol-9-yl) - [1,1' -biphenyl ] -2-yl) -9H-3,9' -bicarbazole (compound a) as a white solid (93g, 91% yield).
Synthesis of 2,2' -bis (9H- [3,9' -bicarbazole ] -9-yl) -1,1' -biphenyl (Compound B):
Figure BDA0002777829770000631
step 1: to a 500mL dry thick walled reaction flask equipped with an electromagnetic stirrer was added 9H-3,9' -bicarbazole (30g, 90mmol), potassium phosphate (38.3g, 181mmol), 1-bromo-2-fluorobenzene (14.80mL, 135mmol) and N, N-dimethylacetamide (150mL) under nitrogen, and the flask was sealed with a threaded cap and heated to 160 ℃ in an oil bath. After 24 hours, Thin Layer Chromatography (TLC) indicated that new spots appeared and that unreacted 9H-3,9' -bicarbazole was present. The reaction was continued for 17 hours and cooled to room temperature. TLC indicated complete consumption of 9H-3,9' -bicarbazole. The reaction mixture was added to 2L of ice-cold water. The brown gummy solid precipitate was filtered and washed with water and air dried. The solid was suspended in heptane and stirred for 2 hours, sonicated for 90 minutes and stirred for 1 hour. The suspension was filtered to give 9- (2-bromophenyl) -9H-3,9' -bicarbazole (22.5g, 46.2mmol) as an off-white powder (24.2g, 98% yield).
Step 2: to a 1L dry 3-neck flask equipped with a magnetic stirrer and a thermowell was added 9- (2-bromophenyl) -9H-3,9' -bicarbazole (22.5g, 46.2mmol) under nitrogen. Anhydrous THF (231ml) was added via cannula and the solution was cooled to-72 ℃. Sec-butyllithium (57.7ml, 81mmol) was added dropwise over 40 minutes using an addition funnel. The mixture was allowed to warm to-40 ℃ over 90 minutes. TLC indicated complete disappearance of bromide. The mixture was cooled to-68 ℃ and 2-isopropoxy-4, 4,5, 5-tetramethyl-1, 3, 2-dioxaborolan-tane (16.48ml, 81mmol) was added dropwise. The reaction mixture was slowly warmed to room temperature overnight (about 16 hours). The mixture was cooled in an ice bath and saturated aqueous ammonium chloride (100mL) was carefully added and stirred for 10 minutes. Water (100mL) was added and the organic layer was separated. The aqueous layer was extracted with DCM, dried over sodium sulfate, filtered and the filtrate evaporated to dryness to give a gummy off-white solid. The material was wet milled in heptane and filtered to give 9- (2- (4,4,5, 5-tetramethyl-1, 3, 2-dioxaborolan-2-yl) phenyl) -9H-3,9' -bicarbazole as an off-white powder (18.25g, 86% yield).
And step 3: 9- (2-bromophenyl) -9H-3,9' -bicarbazole (12.5g, 25.6mmol), 9- (2- (4,4,5, 5-tetramethyl-1, 3, 2-dioxaborole) were stirred in a thick-walled reaction flask equipped with a magnetic stirrerPent-2-yl) phenyl) -9H-3,9' -bicarbazole (18.85g, 28.2mmol), potassium carbonate (10.63g, 77mmol), THF (55mL) and water (21mL) and the reaction mixture was degassed for 10 min. To this mixture was added Pd (PPh)3)4(1.482g, 1.282mmol) and degassed for 5 minutes. The flask was sealed and heated to 90 ℃ for 3.5 days. The reaction mixture was cooled to room temperature, the organic layer was separated, and the aqueous layer was extracted with DCM. The combined organic layers were dried over sodium sulfate and filtered. The filtrate was concentrated to dryness and the resulting residue was dissolved in hot toluene and passed through a bed of silica. Fractions containing product were combined and concentrated. The resulting solid was wet-milled in methanol for 3 hours and filtered. The solid is further wet milled in acetone to obtain 2,2 '-bis (9H- [3,9' -bicarbazole)]-9-yl) -1,1' -biphenyl (compound B) (18.25g, 86% yield).
The OLED devices were fabricated using compound a and compound B as single hosts for sky blue Ir emitters (emitter 1) or as co-hosts for deep blue Pt emitters (emitter 2). Device performance results are shown in tables 1 and 2, respectively, where EQE and voltage are at 10mA/cm2Lower acquisition and lifetime (LT90) at 20mA/cm2The luminance decreases to 90% of the initial luminance at a constant current density of (1). The following compounds were used in the apparatus.
Figure BDA0002777829770000641
Figure BDA0002777829770000651
The OLED structure was grown on a glass substrate pre-coated with an Indium Tin Oxide (ITO) layer with a sheet resistance of 15- Ω/sq. Prior to any organic layer deposition or coating, the substrate was degreased with a solvent, then treated with oxygen plasma at 100 mtorr, 50W for 1.5 minutes and treated with UV ozone for 5 minutes. The apparatus in tables 1 and 2 was carried out by thermal evaporation under high vacuum (C:)<10-6Tray). The anode electrode is
Figure BDA0002777829770000652
ITO of (2). All devices were made immediately after nitrogen glovebox (H)2O and O2<1ppm) with a glass lid, sealed with an epoxy resin, with a desiccant incorporated inside the package. The doping percentage is volume percentage. The device is made to have two different device configurations.
The organic layers in the first assembly consist of, in order: the ITO surface,
Figure BDA0002777829770000653
Compound 1(HIL),
Figure BDA0002777829770000654
Compound 2(HTL),
Figure BDA0002777829770000655
A host doped with 20% of the emitter 1(EML),
Figure BDA0002777829770000656
Compound 3(BL),
Figure BDA0002777829770000661
Compound 4(ETL),
Figure BDA0002777829770000662
Compound 5(EIL), followed by
Figure BDA0002777829770000663
Al (cathode). Device performance of devices having emitter 1 and using host compound a, compound B, and comparative example a are shown in table 1. The voltages, EQE and LT90 for devices example 1 and example 2 are reported relative to the values for comparative example 1.
The organic layers in the second assembly shown in table 2 consist of the following in order: the ITO surface,
Figure BDA0002777829770000664
Compound 1(HIL),
Figure BDA0002777829770000665
Compound 2(HTL),
Figure BDA0002777829770000666
Main body for use in EML (EBL),
Figure BDA0002777829770000667
A host doped with 40% of compound 7 and doped with 12% of emitter 2(EML),
Figure BDA0002777829770000668
A compound of (7) (BL),
Figure BDA0002777829770000669
Compound 5 doped with 35% of compound 8(ETL),
Figure BDA00027778297700006610
Compound 5(EIL), followed by
Figure BDA00027778297700006611
Al (cathode). Device performance of devices having emitter 2 and using host compound a, compound B, and comparative example a are shown in table 2. The voltages, EQE and LT90 for devices example 3 and example 4 are reported relative to the values for comparative example 2.
TABLE 1
Figure BDA00027778297700006612
TABLE 2
Figure BDA00027778297700006613
The above data indicate that two compounds of the invention: both compound a and compound B, as a host, exhibited a longer lifetime (LT90) than the comparative compound (comparative example a). Compound a and compound B extended the lifetime by 14% to 75% over any value that could be attributed to experimental error, and the observed improvement was significant. The significant performance improvements observed in the above data are unexpected based on the fact that compound a and compound B have similar structures as comparative example a, differing only by the additional carbazole substitution. Without being bound by any theory, this improvement may be attributed to the improved hole transport capability of the bicarbazole moiety compared to the monocarbazole.

Claims (20)

1. A compound comprising the structure of formula I
Figure FDA0002777829760000011
Wherein Y isiIs that
Figure FDA0002777829760000012
And Y isjIs that
Figure FDA0002777829760000013
Wherein:
RA、RB、RCand RDEach independently represents zero substitution, mono-substitution, di-substitution, or the maximum permissible substitution;
each RA、RB、RCAnd RDIndependently hydrogen or a substituent selected from the group consisting of: deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, oxyboronyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, and combinations thereof;
RA、RB、RCand RDComprises a carbazole moiety;
X1-X16each of which is independently C or N; and is
RA、RB、RCAnd RDAny two of which can be joined or fused together to form a ring.
2. The compound of claim 1, wherein each RA、RB、RCAnd RDIndependently hydrogen or a substituent selected from the group consisting of: deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, oxyboronyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, thio, and combinations thereof.
3. The compound of claim 1, wherein RA、RB、RCAnd RDComprises a carbazole group.
4. The compound of claim 1, wherein RA、RB、RCAnd RDAre joined together to form a fused 5-or 6-membered carbocyclic or heterocyclic ring.
5. The compound of claim 1, wherein X1-X16Is N.
6. The compound of claim 1, wherein X1-X16Is C.
7. The compound of claim 1, wherein YiSelected from the group consisting of:
Figure FDA0002777829760000021
Figure FDA0002777829760000031
8. the compound of claim 1, wherein YiSelected from the group consisting of Y1-Y36Group of and YjSelected from the group consisting of Y1-Y43Group of (A) wherein Y1-Y43Has the following structure:
Figure FDA0002777829760000032
Figure FDA0002777829760000041
Figure FDA0002777829760000051
Figure FDA0002777829760000061
Figure FDA0002777829760000071
9. the compound of claim 1, wherein the compound of formula I is selected from the group consisting of:
Figure FDA0002777829760000072
Figure FDA0002777829760000081
Figure FDA0002777829760000091
Figure FDA0002777829760000101
Figure FDA0002777829760000111
Figure FDA0002777829760000121
Figure FDA0002777829760000131
10. an Organic Light Emitting Device (OLED) comprising:
an anode;
a cathode; and
an organic layer disposed between the anode and the cathode, wherein the organic layer comprises a compound of formula I
Figure FDA0002777829760000132
Wherein Y isiIs that
Figure FDA0002777829760000133
And Y isjIs that
Figure FDA0002777829760000134
Wherein:
RA、RB、RCand RDEach independently represents zero substitution, mono-substitution, di-substitution, or the maximum permissible substitution;
each RA、RB、RCAnd RDIndependently hydrogen or a substituent selected from the group consisting of: deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, oxyboronyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, and combinations thereof;
RA、RB、RCand RDComprises a carbazole moiety;
X1-X16each of which is independently C or N; and is
Any two substituents can be joined or fused together to form a ring.
11. The OLED of claim 10, wherein the organic layer further comprises a second compound comprising a chemical structure selected from the group consisting of: triazines, pyrimidines, pyridine, 9-dioxa-13 b-boranaphtho [3,2,1-de ] anthracene, azanaphthalene, azafluorene, azatriphenylene, azacarbazole, azaindolocarbazole, azadibenzothiophene, azadibenzofuran, and azadibenzoselenophene, as well as aza- (5, 9-dioxa-13 b-boranaphtho [3,2,1-de ] anthracene).
12. The OLED according to claim 11, wherein the second compound is selected from the group consisting of:
Figure FDA0002777829760000141
wherein:
K1'is O or S;
K2'、K3'and K4'Is N or CR9
K5'Selected from the group consisting of O, S and NR10A group of compounds; and is
R1、R2、R3、R4、R5、R6、R7、R8、R9And R10Independently hydrogen or a substituent selected from the group consisting of: deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, oxyboronyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, and combinations thereof.
13. The OLED according to claim 11, wherein the second compound is selected from the group consisting of:
Figure FDA0002777829760000151
Figure FDA0002777829760000161
14. the OLED according to claim 10 wherein the organic layer further comprises a compound of formula II
Figure FDA0002777829760000171
Wherein:
m' is Pt or Pd;
rings a ', B', C 'and D' each independently represent a 5-or 6-membered carbocyclic or heterocyclic ring;
X1'-X12'each independently selected from the group consisting of carbon and nitrogen;
RA'、RB'、RC'and RD'Each independently represents mono-to the maximum allowed number of substitutions or no substitution;
each RA'、RB'、RC'And RD'Independently is hydrogen or is selected fromA substituent of the group consisting of: deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, oxyboronyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, and combinations thereof;
n' is 0 or 1;
L1'、L2'and L3'Each independently selected from the group consisting of: direct bond, BRR', NR, PR, O, S, Se, C-O, S-O, SO2CRR ', SiRR ', GeRR ', and combinations thereof;
when n' is 1, L4'Selected from the group consisting of: direct bond, BRR', NR, PR, O, S, Se, C-O, S-O, SO2CRR ', SiRR ', GeRR ', and combinations thereof;
when n' is 0, L4'Is absent;
each Y is1'、Y2'、Y3'And Y4'Selected from the group consisting of a direct bond, O, and S;
wherein Y is1'、Y2'、Y3'And Y4'At least two of which are direct bonds.
15. The OLED according to claim 14 wherein the compound of formula II is a tetradentate Pt complex having at least one portion of a ligand selected from the group consisting of:
Figure FDA0002777829760000181
wherein:
each Y is1To Y13Independently selected from the group consisting of carbon and nitrogen;
y' is selected from the group consisting of: b Re、N Re、P Re、O、S、Se、C=O、S=O、SO2、CReRf、SiReRfAnd GeReRf
ReAnd RfOptionally fused or joined to form a ring;
each Ra、Rb、RcAnd RdMay independently represent mono-to the maximum possible number of substitutions, or no substitution;
each Ra、Rb、Rc、Rd、ReAnd RfIndependently selected from the group consisting of: hydrogen, deuterium, halo, alkyl, cycloalkyl, heteroalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, and combinations thereof; and is
Ra、Rb、RcAnd RdAny two adjacent substituents of (a) are optionally fused or joined to form a ring.
16. The OLED of claim 14 wherein the compound of formula II is selected from the group consisting of:
Figure FDA0002777829760000191
Figure FDA0002777829760000201
wherein:
l is selected from the group consisting of: o, S, Se, NR, BR, BRR ', C-O, S-O, CRR ', SiRR ', and combinations thereof; and is
Each RA、RB、RC、RD、REAnd RFIndependently hydrogen or a substituent selected from the group consisting of: deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, oxyboronyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroarylAcyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino and combinations thereof.
17. The OLED of claim 10 wherein the compound is a host and the organic layer is an emissive layer comprising a phosphorescent emitter.
18. The OLED of claim 17 wherein the phosphorescent emitter is a transition metal complex having at least one ligand selected from the group consisting of:
Figure FDA0002777829760000202
Figure FDA0002777829760000211
wherein:
each Y is1To Y13Independently selected from the group consisting of C and N;
y' is selected from the group consisting of: b Re、N Re、P Re、O、S、Se、C=O、S=O、SO2、CReRf、SiReRfAnd GeReRf
ReAnd RfOptionally fused or joined to form a ring;
each Ra、Rb、RcAnd RdIndependently represent zero, single or up to the maximum permissible substitutions for their consecutive rings;
Ra、Rb、Rc、Rd、Reand RfEach of which is independently selected from the group consisting of: hydrogen, deuterium, halo, alkyl, cycloalkyl, heteroalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynylAryl, heteroaryl, acyl, carbonyl, carboxylic acid, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, and combinations thereof; and R isa、Rb、RcAnd RdTwo adjacent substituents in (a) are optionally fused or joined to form a ring or to form a multidentate ligand.
19. A consumer product comprising an organic light emitting device, the organic light emitting device comprising:
an anode;
a cathode; and
an organic layer disposed between the anode and the cathode,
wherein the organic layer comprises a compound of formula I
Figure FDA0002777829760000221
Wherein Y isiIs that
Figure FDA0002777829760000222
And Y isjIs that
Figure FDA0002777829760000223
Wherein:
RA、RB、RCand RDEach independently represents zero substitution, mono-substitution, di-substitution, or the maximum permissible substitution;
each RA、RB、RCAnd RDIndependently hydrogen or a substituent selected from the group consisting of: deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, oxyboronyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, thio, sulfinyl, sulfonyl, phosphino, and combinations thereof;
RA、RB、RCand RDComprises a carbazole moiety;
X1-X16each of which is independently C or N; and is
Any two substituents can be joined or fused together to form a ring.
20. A formulation comprising a compound of formula I according to claim 1.
CN202011271522.7A 2019-11-14 2020-11-13 Organic electroluminescent material and device Pending CN112794814A (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US16/683,507 US11515489B2 (en) 2018-11-28 2019-11-14 Host materials for electroluminescent devices
US16/683,507 2019-11-14
US202063017220P 2020-04-29 2020-04-29
US63/017,220 2020-04-29
US17/086,989 US11889708B2 (en) 2019-11-14 2020-11-02 Organic electroluminescent materials and devices
US17/086,989 2020-11-02

Publications (1)

Publication Number Publication Date
CN112794814A true CN112794814A (en) 2021-05-14

Family

ID=75806163

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011271522.7A Pending CN112794814A (en) 2019-11-14 2020-11-13 Organic electroluminescent material and device

Country Status (2)

Country Link
KR (1) KR20210059652A (en)
CN (1) CN112794814A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023273384A1 (en) * 2021-06-30 2023-01-05 京东方科技集团股份有限公司 Thermally activated delayed fluorescent material, organic light-emitting device and display apparatus

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007123392A (en) * 2005-10-26 2007-05-17 Konica Minolta Holdings Inc Organic electroluminescence device, display device and lighting device
JP2008074939A (en) * 2006-09-21 2008-04-03 Konica Minolta Holdings Inc Organic electroluminescence element material, organic electroluminescence element, display device and illumination device
JP4552382B2 (en) * 2003-03-06 2010-09-29 コニカミノルタホールディングス株式会社 ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, DISPLAY DEVICE AND LIGHTING DEVICE
US20170069853A1 (en) * 2015-09-09 2017-03-09 Samsung Electronics Co., Ltd. Condensed cyclic comopund and organic light-emitting device including the same
CN108948044A (en) * 2017-05-18 2018-12-07 环球展览公司 Electroluminescent organic material and device
US20190341557A1 (en) * 2018-05-06 2019-11-07 Universal Display Corporation Host materials for electroluminescent devices
CN111864122A (en) * 2019-04-29 2020-10-30 环球展览公司 Organic electroluminescent material and device

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4552382B2 (en) * 2003-03-06 2010-09-29 コニカミノルタホールディングス株式会社 ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, DISPLAY DEVICE AND LIGHTING DEVICE
JP2007123392A (en) * 2005-10-26 2007-05-17 Konica Minolta Holdings Inc Organic electroluminescence device, display device and lighting device
JP2008074939A (en) * 2006-09-21 2008-04-03 Konica Minolta Holdings Inc Organic electroluminescence element material, organic electroluminescence element, display device and illumination device
US20170069853A1 (en) * 2015-09-09 2017-03-09 Samsung Electronics Co., Ltd. Condensed cyclic comopund and organic light-emitting device including the same
CN108948044A (en) * 2017-05-18 2018-12-07 环球展览公司 Electroluminescent organic material and device
US20190341557A1 (en) * 2018-05-06 2019-11-07 Universal Display Corporation Host materials for electroluminescent devices
CN111864122A (en) * 2019-04-29 2020-10-30 环球展览公司 Organic electroluminescent material and device

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023273384A1 (en) * 2021-06-30 2023-01-05 京东方科技集团股份有限公司 Thermally activated delayed fluorescent material, organic light-emitting device and display apparatus

Also Published As

Publication number Publication date
KR20210059652A (en) 2021-05-25

Similar Documents

Publication Publication Date Title
EP3124488B1 (en) Organic electroluminescent materials and devices
EP3231809B1 (en) Organic electroluminescent materials and devices
EP3297051B1 (en) Organic electroluminescent materials and devices
KR20160119713A (en) Organic electroluminescent materials and devices
CN111606939B (en) Organic electroluminescent material and device
JP2024055934A (en) Host Materials for Electroluminescent Devices
EP3305796B1 (en) Organic electroluminescent materials and devices
EP3398953B1 (en) Organic electroluminescent materials and devices
CN112442055A (en) Organic electroluminescent material and device
CN110713492A (en) Organic electroluminescent material and device
CN111138495A (en) Organic electroluminescent material and device
CN114989192A (en) Organic electroluminescent material and device
EP3323822B1 (en) Organic electroluminescent materials and devices
CN112625066A (en) Organic electroluminescent material and device
CN111303168A (en) Host materials for electroluminescent devices
CN110903324A (en) Organic electroluminescent material and device
EP3689889B1 (en) Organic electroluminescent materials and devices
CN110563768B (en) Organic electroluminescent material and device
CN112390828A (en) Organic electroluminescent material and device
CN112794814A (en) Organic electroluminescent material and device
CN114315867A (en) Fast phosphors using HP2H ligand
CN112390827A (en) Organic electroluminescent material and device
CN111925397A (en) Organic electroluminescent material and device
CN111747988A (en) Organic electroluminescent material and device
CN111909216B (en) Organic electroluminescent material and device

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination